Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study

Background: The majority of therapies have generally targeted fasting glucose control, and current mealtime insulin therapies have longer time action profiles than that of endogenously secreted insulin. The primary purpose of this study was to assess both glucose time-in-range (TIR: 70–180 mg/dL) an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Technol Ther
Main Authors: Akturk, Halis Kaan, Snell-Bergeon, Janet K., Rewers, Amanda, Klaff, Leslie J., Bode, Bruce W., Peters, Anne L., Bailey, Timothy S., Garg, Satish K.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc., publishers 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6161328/
https://ncbi.nlm.nih.gov/pubmed/30207748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2018.0200
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados